Valsartan and hydrochlorothiazide (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the Valsartan and hydrochlorothiazide drug offered from Actavis Pharma, Inc.. This Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
| NON-PROPRIETARY NAME: | Valsartan and hydrochlorothiazide |
| SUBSTANCE NAME: | VALSARTAN; HYDROCHLOROTHIAZIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2013-03-21 |
| END MARKETING DATE: | 0000-00-00 |
Valsartan and hydrochlorothiazide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Valsartan and hydrochlorothiazide from Actavis Pharma, Inc. |
| LABELER NAME: | Actavis Pharma, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 80; 12.5(mg/1; mg/1) |
| START MARKETING DATE: | 2013-03-21 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0591-2315_21442b24-16f4-4d77-9229-cd3ff2784bb3 |
| PRODUCT NDC: | 0591-2315 |
| APPLICATION NUMBER: | ANDA091519 |
Other VALSARTAN; HYDROCHLOROTHIAZIDE Pharmaceutical Manufacturers / Labelers:
